Bactiguard Holding AB logo

BACTI B - Bactiguard Holding AB News Story

SEK171.5 -4.5  -2.6%

Last Trade - 25/09/20

Sector
Healthcare
Size
Mid Cap
Market Cap £494.8m
Enterprise Value £515.5m
Revenue £19.3m
Position in Universe 410th / 1783

BRIEF-New clinical studies show that Bactiguard-coated catheters reduce hospital acquired infections

Mon 14th September, 2015 7:00am
Sept 14 (Reuters) - Bactiguard Holding AB  BACTIb.ST : 
    * New clinical studies show that Bactiguard-coated catheters reduce hospital acquired 
infections  
    * Says Bactiguard-coated Foley catheters and endotracheal tubes reduce catheter associated 
urinary tract infections and ventilator associated pneumonia 
    * Other study shows a 67 pct lower incidence of ventilator associated pneumonia for patients 
with Bactiguard-coated endotracheal tubes (BIP ETT), compared to patients with standard ETTs 
 
Source text for Eikon:  ID:nWkrim8826  
     
Further company coverage:  BACTIb.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.